INVESTOR AB
Exchange sourced- Local ticker
- INVE B
- ISIN
- SE0015811963
- Exchange
- NASDAQ Stockholm AB, XSTO
- Primary market
- Sweden
Figures as of 6 November 2026, 18:00 UTC. Refreshed weekly.
What we hold
Counted over 26 years, by bundle.
Counts are classified documents, not pages. A name with no filings in a bundle still shows the bundle, so an empty row is a fact about the company rather than a gap in coverage.
| Bundle | Documents held | Most recent |
|---|---|---|
| Core Financials & GovernanceAnnual and interim reports, financial statements, AGM and remuneration material | 307 | 16 Oct 2026Interim Management Statement January-September 2026 |
| Corporate EventsAnnouncements, results releases, corporate actions, director dealings | 621 | 4 Nov 2026Investor hosts Capital Markets Update today |
| Earnings IntelligenceEarnings call transcripts, results presentations, capital markets days | 144 | 16 Oct 2026Q3 Presentation (Interim Management Statement January-September 2026) |
| Sustainability & PoliciesSustainability reports, transition plans, supplier and human rights policies | 20 | 8 Jan 2026Code of Conduct |
| MiscellaneousEverything the taxonomy places outside the four bundles above | 72 | 31 Aug 2026Proxy Voting Annual Report, N-PX - Annual Report of proxy voting record of management investment companies |
| All bundles | 1,121 |
Most recent documents
The ten most recent, newest first. Every document carries the date it was published, the classification we assigned, and its length.
The full record for INVESTOR AB, every document in it and the whole archive behind it, is in Orbit Insight. Opening a document costs one credit and trial accounts start with 500.
| Document | Bundle | Published | Pages | Open |
|---|---|---|---|---|
| Investor hosts Capital Markets Update todayPress Release | Events | 4 Nov 2026 | 1 | Open in Insight |
| Investor Holds Capital Markets Update TodayPress Release | Events | 4 Nov 2026 | 1 | Open in Insight |
| New leaders appointed for Mölnlycke Health CarePress Release | Events | 3 Nov 2026 | 1 | Open in Insight |
| Morten Henneveld appointed interim CEO of Atlas AntibodiesPress Release | Events | 2 Nov 2026 | 1 | Open in Insight |
| Morten Henneveld appointed acting CEO of Atlas AntibodiesPress Release | Events | 2 Nov 2026 | 1 | Open in Insight |
| Interim Management Statement January-September 2026Interim reports | Financials | 16 Oct 2026 | 39 | Open in Insight |
| Q3 Presentation (Interim Management Statement January-September 2026)Investor Presentation | Earnings | 16 Oct 2026 | 33 | Open in Insight |
| Q3 2026Earnings Call Transcript - ECM | Earnings | 16 Oct 2026 | 10 | Open in Insight |
| Q3 2026- PresenationConference Call Presentation | Earnings | 16 Oct 2026 | 33 | Open in Insight |
| Invitation to Investor's Q3 2026 webcastPress Release | Events | 2 Oct 2026 | 1 | Open in Insight |
How it reaches you. And how fast.
The same facts are attached to every name in the universe, which is what makes a coverage answer checkable rather than a claim.
Open the full Sweden coverage detail for the exchanges behind that company count, what the year’s volume is made of, and how the median latency is distributed.
Follow INVESTOR AB and the rest of your universe.
Paste every name you hold into Orbit Insight and get this view for all of them, plus the documents themselves. Trial accounts start with 500 credits.
Missing a filing for SE0015811963?
If a document you expect for this name is not held, tell us which one and we will assess a backfill.